Charisse R. Lillie - 31 Mar 2025 Form 4 Insider Report for EXELON CORP (EXC)

Role: Director
Signature: David T. Skinner, attorney-in-fact for Charisse R Lillie
Issuer symbol: EXC
Transactions as of: 31 Mar 2025
Net transactions value: +$41,229
Form type: 4
Filing time: 02 Apr 2025, 14:25:27 UTC
Previous filing: 03 Jan 2025
Next filing: 02 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EXC	Common stock- deferred stock units	Award	$41,229	+933	+12%	$44.19	8,473	31 Mar 2025	By Exelon Corp. Directors Deferred Stock Unit Plan	F1
holding	EXC	Common Stock						7,246	31 Mar 2025	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	EXC	Deferred phantom share equivalents						3,717	31 Mar 2025	Common Stock	3,717		Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Balance includes 68 additional shares acquired through automatic dividend reinvestment.
F2	Phantom share equivalents held in the reporting person's Exelon stock fund account that is part of a multi-fund, non-qualified deferred compensation plan. Phantom share equivalents will be settled for cash on a 1 for 1 basis upon the termination of the reporting person's service to the board of directors.
F3	Balance includes 34 additional phantom share equivalents that were accrued to the account by the plan administrator on the ex-dividend date.